The Jeffrey Epstein VI Foundation funded the development of a mathematical model to understand how cancer cells evolve resistance to inhibitor drug therapy. The research, led by Martin Nowak at Harvard University, revealed that a small percentage of colon cancer cells with an activated KRAS gene are inherently resistant to treatment. This finding has influenced new approaches in cancer therapy, advocating for a cocktail of drugs to target all cell types. The foundation, established by Jeffrey Epstein, supports various scientific and educational initiatives.
documents/EFTA01128840.pdf
{}